Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG). Ozaka M, et al. Among authors: terashima t. Eur J Cancer. 2023 Mar;181:135-144. doi: 10.1016/j.ejca.2022.12.014. Epub 2022 Dec 27. Eur J Cancer. 2023. PMID: 36652891 Free article. Clinical Trial.
Aldo-keto reductase family 1 member B10 is regulated by nucleos(t)ide analogues for chronic hepatitis B.
Orita N, Kawaguchi K, Honda M, Shimode T, Hayakawa N, Terashima T, Komura T, Nishikawa M, Horii R, Nio K, Shimakami T, Takatori H, Arai K, Sakai Y, Yamashita T, Mizukoshi E, Kaneko S, Kagaya T, Yamashita T. Orita N, et al. Among authors: terashima t. Biochem Biophys Res Commun. 2023 Sep 24;674:133-139. doi: 10.1016/j.bbrc.2023.06.093. Epub 2023 Jul 1. Biochem Biophys Res Commun. 2023. PMID: 37419034
Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease: A Case Report.
Miyazawa M, Yanagi M, Chiba T, Kido H, Matsuo T, Nishitani M, Orita N, Takata N, Hayashi T, Seki A, Nakagawa H, Nio K, Terashima T, Iida N, Yamada S, Takatori H, Shimakami T, Arai K, Yamashita T, Mizukoshi E, Honda M, Yamashita T. Miyazawa M, et al. Among authors: terashima t. Intern Med. 2023 Oct 13. doi: 10.2169/internalmedicine.2489-23. Online ahead of print. Intern Med. 2023. PMID: 37839881 Free article.
Gastroduodenitis Associated with Active Ulcerative Colitis Treated with Infliximab: Different Clinical Course in the Colon and Gastroduodenal Lesions.
Hayashi T, Terashima T, Nishitani M, Orita N, Miyazawa M, Seki A, Nakagawa H, Nio K, Iida N, Yamada S, Takatori H, Shimakami T, Yamashita T. Hayashi T, et al. Among authors: terashima t. Intern Med. 2024 Apr 1;63(7):929-935. doi: 10.2169/internalmedicine.2047-23. Epub 2023 Jul 26. Intern Med. 2024. PMID: 37495533 Free PMC article.
A case of frequent hypoglycemic attacks successfully controlled with capecitabine plus temozolomide and 177Lu-DOTATATE peptide receptor radionuclide therapy in a patient with recurrent pancreatic insulinoma.
Terashima T, Yamashita T, Takemura N, Inaki A, Shimizu A, Harada K, Yamashita T, Kinuya S, Hanada K. Terashima T, et al. Clin J Gastroenterol. 2023 Oct;16(5):767-771. doi: 10.1007/s12328-023-01824-8. Epub 2023 Jul 5. Clin J Gastroenterol. 2023. PMID: 37405635
Photodynamic therapy with talaporfin sodium for endoscopically unresectable gastric cancer using a novel simultaneous light-emitting method.
Hayashi T, Hayashi K, Terashima T, Nishitani M, Orita N, Miyazawa M, Seki A, Nakagawa H, Nio K, Iida N, Yamada S, Takatori H, Shimakami T, Yamashita T. Hayashi T, et al. Among authors: terashima t. DEN Open. 2024 Jan 23;4(1):e334. doi: 10.1002/deo2.334. eCollection 2024 Apr. DEN Open. 2024. PMID: 38264465 Free PMC article.
[The locoregional therapy for hepatocellular carcinoma].
Yamashita T, Terashima T, Yamashita T. Yamashita T, et al. Among authors: terashima t. Nihon Shokakibyo Gakkai Zasshi. 2023;120(1):35-45. doi: 10.11405/nisshoshi.120.35. Nihon Shokakibyo Gakkai Zasshi. 2023. PMID: 36631114 Japanese. No abstract available.
A novel pathologic marker, indoleamine 2,3-dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors-induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment.
Yoshimura K, Tamano Y, Nguyen Canh H, Zihan L, Le Thanh D, Sato Y, Terashima T, Shimoda S, Harada K. Yoshimura K, et al. Among authors: terashima t. Med Mol Morphol. 2023 Jun;56(2):106-115. doi: 10.1007/s00795-022-00344-7. Epub 2023 Jan 4. Med Mol Morphol. 2023. PMID: 36599971
667 results